Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	17.65	71.19	60.52
Graham Fair Price	-17.61	6.15	7.47
PEG	42.15	-0.92	0.65
Price/Book	-3.27	2.64	2.73
Price/Cash Flow	0.00	0.00	0.00
Prices/Earnings	52.30	32.90	21.60
Price/Sales	12.33	17.54	15.61
Price/FCF	0.00	0.00	0.00
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	-10.18	0.45	0.50
Operating Margin	-16.11	0.35	0.41
ROA	-34.87	< 0.005	< 0.005
ROE	0.03	0.02	-36.49
ROIC	0.01	< 0.005	-17.55
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	< 0.005	0.04	-87.98
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.40	-0.25	-36.58
EPS QOQ	0.33	-0.36	7.14
FCF QOQ	0.00	0.00	0.00
Revenue QOQ	0.26	-0.11	-57.45
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	37.63	24.55	-34.75
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.79	0.79	-0.58
Quick Ratio	0.66	5.61	752.99
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	8.85	9.15	3.38
Cash	0.59	0.46	-22.07
Capex	n.A.	n.A.	n.A.
Free Cash Flow	n.A.	n.A.	n.A.
Revenue	1.55	1.38	-10.98
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	1.03	11.25	993.70
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	35.23	41.60	18.10
Naive Interpretation	Member

06 - Financial Health · Bad

Rating